Top Stock Gainers
Explore the biggest stock gainers today along with up-to-date performance data, including the latest price, share price changes, trading volume, and more. We cover the top stock gainers every day with market data, news, and analysis from our Foolish experts.
Related Articles
Featured Article
Why Nevro Stock Lagged the Market on Thursday
Eric Volkman
|
Feb 22, 2024
Despite convincing beats on its latest set of quarterly figures, the market wasn't all that impressed with the company's latest developments.
Why Sage Therapeutics Stock Sank Today
Eric Volkman
|
Nov 7, 2023
A secondary stock sale and underwhelming quarterly results sent investors to the off-ramp.
Is Sage Therapeutics Stock in Trouble After Dropping 50% in a Month?
David Jagielski
|
Aug 24, 2023
The pharmaceutical company's growth prospects have taken a big hit.
22nd Century Group (XXII) Q2 2023 Earnings Call Transcript
Motley Fool Transcribing
|
Aug 14, 2023
XXII earnings call for the period ending June 30, 2023.
Why Shares of Sage Therapeutics Slumped This Week
Jim Halley
|
Aug 11, 2023
The company got bad news from the FDA and saw increased losses.
Is Sage Therapeutics a Contrarian Buy?
George Budwell
|
Aug 8, 2023
A regulatory setback weighed heavily on the drugmaker's shares Monday.
Why Sage Therapeutics Stock Is Crashing Today
Keith Speights
|
Aug 7, 2023
Sage's regulatory win wasn't enough to offset an even bigger regulatory loss.
Why Shares of Nevro Are Down Wednesday
Jim Halley
|
Aug 2, 2023
The medical device maker saw increased revenue, but earnings lagged estimates.
Why Sage Therapeutics Stock Is Tumbling Today
George Budwell
|
Jul 26, 2023
A partner's perceived lack of enthusiasm for an upcoming regulatory decision is spooking investors today.
22nd Century Group (XXII) Q1 2023 Earnings Call Transcript
Motley Fool Transcribing
|
May 9, 2023
XXII earnings call for the period ending March 31, 2023.
View More Articles